Cogstate Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer's disease and dementia, preclinical Alzheimer's disease, pediatrics and rare disease, Parkinson's disease, multiple sclerosis, schizophrenia, oncology, safety, and sleep and mood disorders. The company also designs and provides quality assurance services in clinical trials focused on the administration, scoring, and recording of conventional brain health assessments. In addition, it develops a tool for primary care physicians and/or hospitals to assess cognitive decline. Its technology and associated services are used to quantify the effect of disease and drugs, devices, or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The company serves biopharmaceutical companies, academic institutions, physicians, and patients. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Key Metrics
PE ratio
27.25
PB ratio
5.34
Dividend yield
0.91%
Beta
-0.04
Market cap
$373.99M
Enterprise value
$334.86M
Company profile
| Industry / Sector | Health Information Services / Healthcare |
|---|---|
| Website | https://www.cogstate.com |
| Mailing address | 367 Collins Street Level 32 Melbourne VIC 3000 Australia |
| Phone / Fax | 61 3 9664 1300 / 61 3 9664 1301 |
Dividends
More: Cogstate Dividend history, yield and payout ratio
Dividend yield
0.91%
Dividend amount
$0.02
Payout ratio
0.00%
5Y Avg. yield
-%
Cogstate paid $0.02 dividend and the ex-dividend date was 27 Aug 2025.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.CGS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Cogstate.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Bradley John O'Connor B.Bus, C.A. | CEO, MD & Executive Director | ||
| Mr. Darren Watson | Chief Financial Officer | ||
| Dr. Pamela Ventola Ph.D. | Chief Science Officer | ||
| Ms. Rachel Colite | Executive VP of Clinical Trials | ||
| Prof. Paul Maruff BBSc (Hons), Ph.D. | Founder & Chief Innovation Officer | ||
| Ms. Kristi Geddes L.L.B. | General Counsel, Joint Company Secretary & Director | ||
| Mr. Kenneth Billard | Chief Commercial Officer | ||
| Dr. Kaycee Sink M.D. | Chief Medical Officer | ||
| Mr. David James Franks BEc, C.A., F Fin, J.P. | Joint Company Secretary | 55 |
Profitability and management effectiveness
Profit margin
19.11%
Operating margin
27.68%
Return on assets
13.41%
Return on equity
22.84%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Cogstate is 373.99M and its enterprise value is 334.86M. The enterprise value to revenue ratio of CGS is 6.31. The enterprise value to EBITDA ratio of CGS is 24.74.
Companies similar to Cogstate (CGS)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Cogstate (ASX:CGS) Frequently Asked Questions
1. What is Cogstate's Stock Symbol?
Cogstate trades on ASX under the ticker symbol "CGS".
2. What is Cogstate's stock price today?
One share of CGS stock can currently be purchased for approximately $2.18.
3. How can I contact Cogstate?
Cogstate's mailing address is 367 Collins Street Level 32 Melbourne VIC 3000 Australia. The company can be reached via phone at 61 3 9664 1300.
4. What is Cogstate's official website?
The official website of Cogstate is https://www.cogstate.com.